Literature DB >> 3131010

Deep vein thrombosis and pulmonary embolism: clinical presentation and pathophysiologic consequences.

A J Comerota1.   

Abstract

Deep vein thrombosis (DVT) and pulmonary embolism (PE) are both characterized by unreliable clinical diagnosis and significant long-term sequelae. In patients with DVT, popliteal valvular insufficiency is associated with increased risk for postphlebitic syndrome. Current data show thrombolytic therapy to be more effective than anticoagulation for DVT, accomplishing significant or complete clearing of the deep venous system in nearly half of all patients treated. Results of investigation show lytic therapy to also be more effective than heparin in treatment of PE, both in terms of acute resolution and long-term function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131010     DOI: 10.1007/bf02577090

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  21 in total

1.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

2.  Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. A comparative study between streptokinase and heparin therapy.

Authors:  R Watz; G F Savidge
Journal:  Acta Med Scand       Date:  1979

3.  Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative study.

Authors: 
Journal:  JAMA       Date:  1974-09-16       Impact factor: 56.272

4.  Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study.

Authors: 
Journal:  JAMA       Date:  1970-12-21       Impact factor: 56.272

5.  Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg.

Authors:  B R Robertson; I M Nilsson; G Nylander
Journal:  Acta Chir Scand       Date:  1970

6.  Long-term sequelae of acute venous thrombosis.

Authors:  D E Strandness; Y Langlois; M Cramer; A Randlett; B L Thiele
Journal:  JAMA       Date:  1983-09-09       Impact factor: 56.272

7.  Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin.

Authors:  V V Kakkar; C Flanc; C T Howe; M O'Shea; P T Flute
Journal:  Br Med J       Date:  1969-03-29

8.  Distribution of venous valvular incompetence in patients with the postphlebitic syndrome.

Authors:  D J Moore; P D Himmel; D S Sumner
Journal:  J Vasc Surg       Date:  1986-01       Impact factor: 4.268

9.  Clinical correlations in the diagnosis of pulmonary embolism.

Authors:  R J Goodall; L J Greenfield
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

10.  Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism.

Authors:  G V Sharma; V A Burleson; A A Sasahara
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.